Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 8
1979 7
1980 6
1981 6
1982 13
1983 20
1984 14
1985 34
1986 33
1987 40
1988 41
1989 45
1990 48
1991 42
1992 33
1993 42
1994 39
1995 40
1996 68
1997 52
1998 69
1999 128
2000 72
2001 79
2002 63
2003 73
2004 97
2005 107
2006 180
2007 164
2008 172
2009 249
2010 241
2011 286
2012 308
2013 305
2014 371
2015 297
2016 361
2017 329
2018 359
2019 331
2020 356
2021 391
2022 265
2023 258
2024 276

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,303 results

Results by year

Filters applied: . Clear all
Page 1
The rotavirus vaccine development pipeline.
Kirkwood CD, Ma LF, Carey ME, Steele AD. Kirkwood CD, et al. Vaccine. 2019 Nov 28;37(50):7328-7335. doi: 10.1016/j.vaccine.2017.03.076. Epub 2017 Apr 7. Vaccine. 2019. PMID: 28396207 Free PMC article. Review.
New rotavirus vaccines, including live oral rotavirus candidates and non-replicating approaches continue to be developed, with the major aim to improve the global supply of rotavirus vaccines and for local implementation, and to improve vacci …
New rotavirus vaccines, including live oral rotavirus candidates and non-replicating approaches continue to be develope …
Rotavirus vaccine efficacy: current status and areas for improvement.
Carvalho MF, Gill D. Carvalho MF, et al. Hum Vaccin Immunother. 2019;15(6):1237-1250. doi: 10.1080/21645515.2018.1520583. Epub 2018 Sep 19. Hum Vaccin Immunother. 2019. PMID: 30215578 Free PMC article. Review.
The difference noted in Rotavirus vaccine efficiency between high and low income countries correlates with the lack of universal access to clean water and higher standards of hygiene. ...Finally, alternative mucosal adjuvants and vaccine expression, storage a …
The difference noted in Rotavirus vaccine efficiency between high and low income countries correlates with the lack of univers …
Rotavirus vaccine (RotaTeq).
Keating GM. Keating GM. Paediatr Drugs. 2006;8(3):197-202; discussion 203-4. doi: 10.2165/00148581-200608030-00008. Paediatr Drugs. 2006. PMID: 16774301 Review.
RotaTeq is a live, oral, pentavalent human-bovine reassortant rotavirus vaccine approved for use in the prevention of G1-G4 rotavirus gastroenteritis in infants and children. ...Rotavirus vaccine and placebo were associated with serious adverse …
RotaTeq is a live, oral, pentavalent human-bovine reassortant rotavirus vaccine approved for use in the prevention of G1-G4 …
Rotavirus Infection, Illness, and Vaccine Performance in Malnourished Children: A Review of the Literature.
Burnett E, Parashar UD, Tate JE. Burnett E, et al. Pediatr Infect Dis J. 2021 Oct 1;40(10):930-936. doi: 10.1097/INF.0000000000003206. Pediatr Infect Dis J. 2021. PMID: 34117200 Free PMC article. Review.
Live, oral rotavirus vaccines are more effective at preventing rotavirus disease in countries with low child mortality compared with high child mortality. ...As malnourished children often have worse outcomes from diarrhea, high rotavirus vaccine …
Live, oral rotavirus vaccines are more effective at preventing rotavirus disease in countries with low child mortality …
Rotavirus Vaccine: Current Use and Future Considerations.
Bruijning-Verhagen P, Groome M. Bruijning-Verhagen P, et al. Pediatr Infect Dis J. 2017 Jul;36(7):676-678. doi: 10.1097/INF.0000000000001594. Pediatr Infect Dis J. 2017. PMID: 28383393 Review. No abstract available.
Post-Rotavirus Vaccine Enteropathogen Landscape.
Ballard SB, Gilman RH. Ballard SB, et al. Pediatr Rev. 2023 Mar 1;44(3):182-184. doi: 10.1542/pir.2022-005565. Pediatr Rev. 2023. PMID: 36854827 No abstract available.
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF. Deen J, et al. Hum Vaccin Immunother. 2018 Feb 1;14(2):495-499. doi: 10.1080/21645515.2017.1403705. Epub 2017 Dec 21. Hum Vaccin Immunother. 2018. PMID: 29135339 Free PMC article. Review.
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rot …
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus …
Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.
Mahmud-Al-Rafat A, Muktadir A, Muktadir H, Karim M, Maheshwari A, Ahasan MM. Mahmud-Al-Rafat A, et al. Infection. 2018 Feb;46(1):15-24. doi: 10.1007/s15010-017-1082-4. Epub 2017 Oct 19. Infection. 2018. PMID: 29047020 Review.
METHODS: We searched electronic databases including PubMed and Google scholar using the following words: "features of rotavirus," "epidemiology of rotavirus," "rotavirus serotypes," "rotavirus in Bangladesh," "disease burden of rotavirus," "r …
METHODS: We searched electronic databases including PubMed and Google scholar using the following words: "features of rotavirus," "ep …
Recommendations for rotavirus vaccine.
Lee PI, Chen PY, Huang YC, Lee CY, Lu CY, Chang MH, Lin YZ, Chiu NC, Ni YH, Chen CM, Chang LY, Tang RB, Huang LM, Huang YF, Hwang KP, Hwang B, Lin TY. Lee PI, et al. Pediatr Neonatol. 2013 Dec;54(6):355-9. doi: 10.1016/j.pedneo.2013.03.019. Epub 2013 Jun 6. Pediatr Neonatol. 2013. PMID: 23746943 Free article. Review.
Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a live, attenuated monovalent rotavirus vaccine and a pentavalent, human-bovine reassortant rotavirus vaccine. ...Th …
Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a li …
Challenges to Developing a Rotavirus Vaccine.
Offit PA. Offit PA. Viral Immunol. 2018 Mar;31(2):104-108. doi: 10.1089/vim.2017.0121. Epub 2017 Dec 21. Viral Immunol. 2018. PMID: 29265955 Review.
In the United States, before the licensure of vaccines, rotavirus infections accounted for 2.7 million cases of gastroenteritis annually. Here are described the history and challenges surrounding the development of a rotavirus vaccine....
In the United States, before the licensure of vaccines, rotavirus infections accounted for 2.7 million cases of gastroenteriti …
6,303 results